Storia in 2 fonti

AstraZeneca, CSPC to form joint venture for biologics manufacturing

AstraZeneca and CSPC Pharmaceutical are strengthening their partnership by establishing a new biologics manufacturing joint venture in China. | AstraZeneca and CSPC Pharmaceutical are strengthening their partnership by establishing a new biologics manufacturing joint venture in China.

Raccontata da

global.chinadaily.com.cn

fiercepharma.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

fiercepharma.comStai leggendo2 g fa

AstraZeneca, CSPC to form joint venture for biologics manufacturing

originale

global.chinadaily.com.cn3 g fa

Chinese drugmaker CSPC and AstraZeneca to jointly build next-gen biologics manufacturing plant

Chinese drugmaker CSPC Pharmaceutical Group said on Wednesday that it had signed a contract with AstraZeneca to establish a joint venture to build a next-generation biologics manufacturing plant in Shijiazhuang, Hebei…

Leggi questa versione →

Timeline cronologica

mercoledì 5 agosto 2026·global.chinadaily.com.cn
Chinese drugmaker CSPC and AstraZeneca to jointly build next-gen biologics manufacturing plant
Chinese drugmaker CSPC Pharmaceutical Group said on Wednesday that it had signed a contract with AstraZeneca to establish a joint venture to build a next-generation biologics…
mercoledì 5 agosto 2026·fiercepharma.com
AstraZeneca, CSPC to form joint venture for biologics manufacturing
AstraZeneca and CSPC Pharmaceutical are strengthening their partnership by establishing a new biologics manufacturing joint venture in China. | AstraZeneca and CSPC…